Poland· PL-100175883
Mannitol 20% Fresenius
A mannitol product containing mannitolum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mannitol is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BC01 (mannitol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Mannitol · ATC B05BC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Mannitolum
- Manufacturer
- Fresenius Kabi Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B05BC01
- ATC class
- Mannitol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990212811
- gtin05909990212828
- gtin05909990212835
- gtin05909991513269
- gtin05909991513276
- gtin05909991513283
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
304 interactions on record for mannitol.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mannitol · interactions on record
304 records
- 14 severe
- 104 moderate
- 5 minor
- 181 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- KanamycinA07AA08severe
- NeomycinB05CA09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mannitol in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARDEAOSMOSOL MA 20%ARDEAPHARMA, a.s., Ševětín
- United StatesMannitolICU Medical Inc.
- United KingdomBronchitol 40mg inhalation powder capsules with deviceChapper Healthcare
- NorwayAridolPharmaxis Europe Limited
- GermanyAridolPharmaxis Europe Limited
- FranceMANNITOL 10 % AGUETTANT, solution pour perfusionAGUETTANT
- SwitzerlandMannitol 20 % Braun, InfusionslösungB. Braun Medical AG
- SpainBRONCHITOL 40 MG POLVO PARA INHALACION, CAPSULAS DURASPharmaxis Europe Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Mannit Fresenius
- Belgium · Mannitol Viaflo Baxter, Mannitol, Viaflo Baxter
- Bulgaria · Манитол Б. Браун, Манитол Бакстер
- Cyprus · Mannitol Demo, Mannitol Βιοσερ
- Czechia · Ardeaosmosol Ma, Manitol Viaflo Baxter
- Germany · Aridol, Mannit-Lösung Serag
- Denmark · Mannitol Fresenius Kabi, Osmohale
- Estonia · Mannitol Fresenius
- Spain · Manitol Mein, Osmofundina
- Finland · Aridol, Mannitol Braun
- France · Mannitol Aguettant, Mannitol B. Braun
- United Kingdom (Northern Ireland) · Mannitol Baxter Healthcare, Osmohale
- Greece · Mannitol Bradex, Mannitol Cooper
- Croatia · Manitol Hztm
- Hungary · Mannisol A, Mannisol B
- Ireland · Mannitol Baxter Holding, Osmohale
- Iceland · Bronchitol, Mannitol Viaflo Baxter
- Italy · Mannitolo Bioindustria L.I.M, Mannitolo Bioindustria L.I.M.
- Liechtenstein · Bronchitol
- Lithuania · Mannitol Fresenius
- Luxembourg · Mannitol Viaflo, Mannitol Viaflo Baxter
- Latvia · Mannitol Fresenius
- Malta · Mannitol Baxter Holding, Mannitol Monico
- Netherlands · Mannitol Baxter, Osmohale
- Norway · Aridol, Bronchitol
- Portugal · Manitol Braun, Manitol Labesfal
- Romania · Manitol Infomed Fluids, Mannitol Vioser
- Sweden · Aridol, Mannitol Fresenius Kabi
- Slovenia · Manitol Hztm
- Slovakia · Infusio Mannitoli, Mannitol Bieffe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9d09928-ff03-4c57-a88a-2e43a86c2e87 GET /v1/drugs/b9d09928-ff03-4c57-a88a-2e43a86c2e87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "200 mg/ml",
"packaging": "05909990212811 ¦ Lz ¦ 6269\n1 butelka 100 ml\n05909990212828 ¦ Lz ¦ 6270\n1 butelka 250 ml\n05909990212835 ¦ Lz ¦ 6271\n1 butelka 500 ml\n05909991513269 ¦ Lz ¦ 149928\n12 butelek 500 ml\n05909991513276 ¦ Lz ¦ 149929\n20 butelek 100 ml\n05909991513283 ¦ Lz ¦ 149930\n12 butelek 250 ml",
"substance": "Mannitolum 200 mg/ml",
"common_name": "Mannitolum",
"pl_product_id": "100175883",
"pozwolenie_nr": "02128",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about mannitol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.